Capital Protection Certificate Pharma-Aktien Bond Sustainable certificate Effective as of 1 December 2022, Raiffeisen Centrobank AG has transferred its certificates business to Raiffeisen Bank International AG including (i) all associated rights and obligations, and (ii) the legal position as issuer of (a) existing securities, i.e. outstanding securities issued by Raiffeisen Centrobank AG, and (b) new securities to be issued. Therefore, as of 1 December 2022, Raiffeisen Bank International AG constitutes the issuer of and the debtor under the securities referred to on this web page (including all securities issued prior to such date). The information below is provided solely for (i) current investors and (ii) investors intending to trade the securities directly on a third-party trading venue. The information does not constitute a recommendation or an offer to buy or an invitation to make a respective offer in relation to these securities.

Bid101.60%
May 15, 2024 18:00:01.893 UTC
Ask103.10%
May 15, 2024 18:00:01.893 UTC
chg. 1D-0.030 (-0.03%)
May 15, 2024 18:00:01.893 UTC
Underlying price (delayed)-
--

Name
Pharma-Aktien Bond
ISIN / WKN
AT0000A1N979 / RC0F3M
Underlying
Sustainability preference
Consideration of Principal Adverse Impacts (PAI)
Capital protection amount
100%
Participation factor
-
Cap
-
Variable interest rate annually
4.00%
Variable payout level
100.00 / 100.00 / 100.00 / 100.00 / 100.00 / 100.00 / 100.00 / 100.00
Underlying price (delayed)
- --
-
Starting value
EUR 100.00
Strike
EUR 100.00
Tradeable unit/nominal value
EUR 1,000
Paid interest rate
4.00% (EUR 40.00) on Sep 14, 2017
4.00% (EUR 40.00) on Sep 14, 2018
4.00% (EUR 40.00) on Sep 16, 2019
4.00% (EUR 40.00) on Sep 16, 2020
4.00% (EUR 40.00) on Sep 16, 2021
4.00% (EUR 40.00) on Sep 15, 2022
4.00% (EUR 40.00) on Sep 14, 2023
About the term

Initial valuation date
Sep 12, 2016
Issue date
Sep 13, 2016
Final valuation date
Sep 11, 2024
Maturity date
Sep 16, 2024

Product classification
Investment Product with Capital Protection
Security type (Eusipa No.)
Capital Protection Certificate (1140)
Capital Protection Certificate Type
coupon orientated
Underlying
Country / region of underlying
-
Suited market expectation
sideways, bullish
Starting value
EUR 100.00
Strike
EUR 100.00
Cap
-
Issue price
100.00%
Spread homogenised
1.50
Spread (in %)
1.48%
Multiplier
-
Product currency
EUR
Underlying currency
EUR
Settlement method
Cash settlement
Taxation
Capital Gains Tax / no Foreign Capital Gains Tax
Listing
Vienna, Stuttgart
Description

The Guarantee Certificate Pharma Stocks Bond provides investors with the opportunity to obtain an annual interest rate of 4%. The interest amount is paid out if all underlying shares (AstraZeneca Plc, Novartis AG and Sanofi SA) quote at/above their respective starting value (=closing price at the initial valuation date) at the current annual valuation date. The certificate will be redeemd at 100% of the nominal value at the end of the term (September 2024).

This certificates complies with the sustainability standard for Raiffeisen Certificates and takes into account important adverse impacts on sustainability factors ("PAIs").

TRADING HOURS

Products on Austrian underlyings

9:15 - 5:30 pm

Products on underlyings of CEE, Eastern Europe and Turkey

 

- Turkey, Czech Republic9:00 - 4:00 pm

- Poland, Hungary, Romania, CEE and Eastern Europe

9:15 - 4:50 pm

Products on other international underlyings and commodities
(incl. Germany and Switzerland)

9:00 - 8:00 pm
INFORMATION

Monday - Friday
8:00 am to 5:30 pm

T: +431717075454
E: info(at)raiffeisencertificates.com